Anaplastic lymphoma kinase (ALK) is a transmembrane receptor tyrosine kinase in the insulin receptor superfamily. We recently demonstrated that the growth factors pleiotrophin (PTN) and midkine (MK) are ligands for ALK and that upon ALK activation, insulin receptor substrate-1 (IRS-1) and other substrates are phosphorylated. Here, the role of IRS-1 in ligand-mediated ALK signaling is investigated in interleukin-3 (IL-3)-dependent 32D murine myeloid cells. These cells do not express ALK and IRS family members, and do not respond to exogenously added PTN or MK. We show that expression of ALK plus IRS-1 renders these cells independent of IL-3 owing to the activation of ALK by endogenous MK. Mutational analysis reveals that this transformed phenotype of 32D cells requires kinase-active ALK as well as the interaction of ALK with IRS-1. Furthermore, 32D/ IRS-1/ALK cells display an enhanced activation of mitogen-activated protein kinase and PI3-kinase pathways, and a selective transcriptional activation of nuclear factor (NF)-jB. Small interfering RNA-mediated knockdown of the endogenous MK or p65/NF-jB revealed that both these are rate limiting for the transformed phenotype induced by ALK plus IRS-1. We conclude that the recruitment of IRS-1 to activated ALK and the activation of NF-jB are essential for the autocrine growth and survival signaling of MK.
Introduction
Anaplastic lymphoma kinase (ALK), a 220 kDa transmembrane receptor tyrosine kinase, and its smaller relative, the 110 kDa leukocyte tyrosine kinase (LTK), belong to the insulin receptor superfamily based on the amino-acid sequence homology of their intracellular kinase domains. ALK was first described as part of an oncogenic fusion tyrosine kinase, nucleophosmin (NPM)-ALK, involved in anaplastic large-cell lymphoma (Morris et al., 1994) . This NPM-ALK fusion protein (residing in the cytoplasm and nucleus) is a constitutively activated tyrosine kinase, owing to the dimerization driven by the N-terminal NPM fusion partner and acts as a transforming oncogene by virtue of its kinase activity (Morris et al., 1994; Kuefer et al., 1997) . Subsequent studies identified several other ALK kinase fusion proteins that support oncogenesis (Hernandez et al., 1999; Colleoni et al., 2000; Lawrence et al., 2000; Ma et al., 2000; Touriol et al., 2000; Trinei et al., 2000) . Full-length ALK was initially described as an orphan receptor tyrosine kinase that shows restricted tissue distribution and is regulated during organ development (Iwahara et al., 1997; Morris et al., 1997) . Several studies show expression of full-length ALK protein in cultured fibroblasts and endothelial cells as well as cell lines derived from epithelial cancers such as pancreatic and breast carcinoma (Stoica et al., 2001 and the neuroectoderm, that is, melanoma (Dirks et al., 2002) , neuroblastoma Stoica et al., 2002) glioblastoma and non-Hodgkin's lymphoma (Delsol et al., 1997) , reviewed by Pulford et al. (2004) .
We identified ALK as a receptor for the growth factor pleiotrophin (PTN) using phage display of a human brain cDNA library with immobilized PTN as a bait and characterized the ligand-receptor interaction in cell-free and cell-based assays (Stoica et al., 2001 ). The phage display had revealed a fragment of the ALK extracellular domain (ECD) as the ligand-binding domain (LBD) and we found that PTN binds the recombinant ALK ECD protein as well as the receptor expressed in intact cells with dissociation constants (K d ) of approximately 30 pM ( ¼ 0.5 ng/ml). Also, antibodies raised to the ALK LBD as well as to PTN inhibited receptor binding of the ligand and signal transduction via ALK as well as biologic effects were observed at EC 50 values close to the K d of PTN binding to the ALK receptor (Stoica et al., 2001; Bowden et al., 2002; Powers et al., 2002) . In support of this, recent work from the laboratory of Paul Mischel (Lu et al., 2005) using different glioblastoma cell line models also reported that ALK phosphorylation and signaling are induced by PTN. This corroborates our earlier work in U87 glioblastoma cells in which depletion of their endogenous ALK by ribozymes specifically blocked growth factor signaling by PTN and tumor growth . In extension of the studies with PTN, its homolog midkine (MK) was also shown to bind to the ALK receptor, albeit with a slightly lower affinity (K d of approximately 100 pM), to induce phosphorylation of the ALK substrate insulin receptor substrate (IRS)-1, activate mitogen-activated protein kinase (MAPK) and PI3-kinase and induce colony formation in soft agar . Blockade of the effect of exogenously added MK by monoclonal antibodies raised against the LBD of ALK revealed the contribution of ALK . Overall, PTN and MK induce a variety of effects in normal and transformed cells or tissues including neurite outgrowth, proliferation, angiogenesis, antiapoptosis and tumor metastasis (see e.g. Fang et al., 1992; Czubayko et al., 1996; Schulte et al., 1996 ; reviewed by Schulte and Wellstein, 1997; Zhang and Deuel, 1999; Muramatsu, 2002) .
Interestingly, in Drosophila, the 560 amino-acid protein jelly belly (Jeb) was shown by mutation and phenotypic analysis to interact with the fly ALK homolog dALK (Englund et al., 2003; Lee et al., 2003) and to induce MAPK signaling. No known homolog of Jeb has yet been described for vertebrates and our recent searches did not reveal a Jeb-related vertebrate protein or gene in the databases of either National Center for Biotechnology Information or EMBL. It was proposed that the activation of dALK by Jeb occurs by heterodimerization of dALK with the membrane-bound Jeb (Freeman, 2003) , and this suggests that other proteins in addition to the PTN/MK growth factors can activate the receptor at least in invertebrates.
Here, we report on the contribution of IRS-1 to signaling through the ALK receptor. The IRS family has four known members, and of the four, IRS-1 has been most extensively studied (White, 1998) . The role of IRS-1 in insulin signaling is well established owing to the fact that IRS-1 is regarded as a critical player in maintaining basic cellular function such as metabolism, cell growth and survival (Chang et al., 2002) . Aberrant expression or activation of IRS-1 has been associated with breast, pancreatic and prostate cancers as well as several rare tumor types (White, 1998 (White, , 2002 Burks and White, 2001; Chang et al., 2002) . In addition to already known interactions, IRS-1 is also thought to be a central element of ERa/insulin-like growth factor (IGF)-1 crosstalk (Surmacz, 2000; Sachdev and Yee, 2001; Surmacz and Bartucci, 2004) .
In the present paper, we analyze the contribution of IRS-1 to ALK signaling using the interleukin-3 (IL-3)-dependent, 32D murine hematopoietic cells that have no detectable ALK and IRS protein expression (Wang et al., 1993; Stoica et al., 2001; White, 2002) . However, surprisingly, we found that 32D cells constitutively express the ALK ligand MK and upon transfection of ALK plus IRS-1, these cells grow and survive independent of IL-3 supplementation. ALK mutations that disrupt kinase activity or the IRS-1-binding site in the intracellular domain of ALK show that kinase activity, as well as interaction with IRS-1, are required for the phenotypic effect. A survey with different promoter/ reporters responsive to growth factor signaling showed a selective activation of the nuclear factor (NF)-kB pathway by the ALK/IRS-1 autocrine activation. Finally, small interfering RNA (siRNA)-mediated targeting of the endogenous MK or of the p65 subunit of NF-kB revealed that both of these factors are ratelimiting for the ALK-mediated effects through IRS-1.
Results

Analysis of the endogenous expression of ALK, LTK and MK in 32D cells
The 32D murine myeloid progenitor cells are IL-3-dependent and have been used extensively to evaluate the role of IRS-1 in IGF-1 receptor and insulin receptor signaling (Wang et al., 1993) . These cells do not express any known IRS family member (Wang et al., 1993) and we reasoned that they thus offer a good model system to analyse the contribution of IRS-1 to ALK signaling. Reverse transcription-polymerase chain reaction (RT-PCR) for murine and human ALK mRNA expression showed an amplified product of the expected size in the positive controls, that is, NIH3T3 fibroblasts and SW13, but no detectable product in 32D cells (Figure 1a) . The ALK homolog LTK is expressed in Ba/F3 cells that have been used to evaluate LTK kinase signaling through a chimeric epidermal growth factor (EGF)/ LTK receptor (Ueno et al., 1996) whereas 32D cells do not express this receptor ( Figure 1b) . As we reported earlier that 32D cells do not express PTN or respond to PTN stimulation (Stoica et al., 2001) , we decided to evaluate whether these cells express detectable levels of the second member of this growth factor family, MK. As shown in Figure 1c cells are an excellent model system to dissect the contribution of IRS-1 to ALK signaling driven by autocrine stimulation through the endogenously expressed ligand, MK.
IL-3-independent growth of 32D cells transfected with ALK plus IRS-1 To investigate the role of IRS-1 in ALK signaling, IRS-1 and ALK expression vectors were introduced into 32D cells. To avoid clonal variability, stable pooled cell lines were established. These pooled cell lines were termed 32D/ALK, 32D/IRS-1 and 32D/IRS-1/ALK. Immunoblotting for ALK and IRS-1 showed that each transfected cell line expressed the appropriate proteins at similar levels ( Figure 2a) . Interestingly, transfected Myc-tagged ALK appeared as a doublet in this cell line and also in other transfected cell lines (data not shown). This doublet might be the result of ALK protein processing because an antibody against ALK also recognizes the doublet and the same pattern was observed with the endogenous ALK in WI38 human fibroblasts (Stoica et al., 2001) . To evaluate the interaction between ALK and IRS-1, we performed co-immunoprecipitations using the C-terminal Myc-tag in ALK as the bait and found that ALK co-precipitates IRS-1 as well as src homology2 domain containing (SHC) proteins from the transfected cells (Figure 2b ). When the overall tyrosine phosphorylation of cellular proteins were evaluated in 32D/IRS-1/ALK, we found an increased tyrosine phosphorylation of numerous proteins migrating above the 66 kDa marker including ALK (Figure 2c , rightmost lane) and saw also enhanced tyrosine phosphorylation of proteins including ALK in 32D/ALK cells, albeit to a lesser extent (Figure 2c , second lane).
We have previously demonstrated that PTN and MK are ligands for ALK (Stoica et al., 2001 and we next assessed whether exogenously added PTN and MK would induce growth effects beyond those induced by the endogenously expressed MK (see Figure 1c) . 5-Bromodeoxyuridine (BrdU) incorporation as a measure of DNA synthesis was enhanced significantly (>10-fold) in 32D/IRS-1/ALK cells relative to the other 32D cell line derivatives in the absence of added growth factor, but addition of PTN or MK did not increase BrdU incorporation significantly relative to the respective controls. All cell lines retained their response to IL-3 added with the WEHI-3 cell conditioned media ( Figure 2d ).
To investigate whether 32D/IRS-1/ALK cells can expand and survive without added IL-3, we monitored the number of cells over time (Figure 2e) . Consistent with published results, 32D and 32D/IRS-1 cells do not survive beyond 48 h after IL-3 withdrawal (Valentinis et al., 1999; Valentinis and Baserga, 2001) and at this time point we also found no viable 32D cells expressing ALK only. In contrast, 32D/IRS-1/ALK cells continued to grow even in the absence of IL-3 (Figure 2e ). 32D/ IRS-1 cells expressing lower levels of ALK also became IL-3 independent (data not shown), indicating that coexpression of IRS-1 and ALK is sufficient for IL-3 independence, a hallmark of transformation of 32D cells (Baserga, 1999 (Baserga, , 2000a Cristofanelli et al., 2000; Valentinis and Baserga, 2001 ).
Knockdown of MK in 32D/IRS-1/ALK
To evaluate the contribution of the endogenously expressed MK (see Figure 1c ) to the IL-3-independent phenotype of 32D/IRS-1/ALK cells, we used two distinct siRNAs to knock down endogenous MK. Both siRNAs effectively reduced MK protein levels in the 32D/IRS-1/ALK cells and this knockdown coincided with a reduction in phospho-ALK (Figure 3a) . Furthermore, the MK siRNA treatment of cells also reduced their proliferation rate in the absence of IL-3 ( Figure 3b ). Growth in the presence of IL-3 was not affected (not shown). In composite, the data from the above sections support the notion that autocrine stimulation by endogenously expressed MK renders 32D/IRS-1/ALK cells independent of IL-3 and we next evaluated whether ALK kinase activity and/or a direct interaction between ALK and IRS-1 are required for this autocrine loop to function.
ALK and IRS-1 interaction is required to induce the transformed phenotype of 32D cells As described above, co-expression of IRS-1 and ALK circumvent IL-3 dependence of 32D cells. To examine whether kinase activity of ALK and/or the interaction between ALK and IRS-1 are required for this effect, mutants of the ATP-(K 1150 F ¼ ALKDATP) and IRS-1-(Y 1096 A ¼ ALKDIRS-1) binding site in the Myc-tagged ALK receptor were generated. In stably transfected pooled 32D cells, phospho-ALK was detectable when the kinase domain was intact, that is, in 32D/ALK, 32D/IRS-1/ALK and 32D/IRS-1/ALKDIRS-1 cells ( Figure 4a , top panel; lanes 2, 4 and 6), whereas phospho-IRS-1 was not detected with the ALKDATP and ALKDIRS-1 mutants ( Figure 4b , top panel; lanes 5 and 6). Immunoprecipitations (IPs) of ALK using the Myc-tag as a bait showed that the two mutated ALK receptors that lack either kinase activity or the IRS-1 binding site do not complex with IRS-1 (Figure 4c Phenotypic analysis of the 32D cell lines carrying different ALK mutants showed that only wild-type ALK was able to support mitogenesis or cell growth of 32D/IRS-1 cells in the absence of IL-3 (Figure 4e and f). To investigate whether the ALK/IRS-1 interaction affects apoptosis in addition to mitogenesis, we monitored Annexin V staining of the 32D cells as an indicator of apoptosis (Figure 4g ). Within 48 h of IL-3 withdrawal, less than 5% of 32D cells lacking either IRS-1 or wild-type ALK were still viable in contrast to 25% of the 32D/IRS-1/ALK cells. Mitogenesis, cell growth and apoptosis assays performed on 32D pooled transfectants with lower levels of mutant ALK receptors resulted in similar observations: 32D cells expressing IRS-1 and only 1/7 (14%) of wild-type ALK protein relative to that shown in Figure 4a (lane 4) showed continuous growth after IL-3 witdrawal and a doubling time of 2 days, whereas all other cell lines without ALK or with ALK mutants underwent apoptosis within 3 days. Taken together, these data provide evidence that the kinase activity of ALK is crucial for the recruitment of other proteins to the receptor and that the phosphorylation of Y 1096 is required for the binding of IRS-1 to the receptor. Furthermore, the activation of ALK and the recruitment of IRS-1 are necessary to induce both the mitogenic and the antiapoptotic pathways, culminating in the transformed phenotype seen in 32D/IRS-1/ALK cells.
Activation of AKT and MAPK in ALK-transfected 32D cells IRS-1 is known to be one of the most efficient transducers of activation signals towards the PI3-kinase (Baserga, 1999 (Baserga, , 2000a Cristofanelli et al., 2000; Valentinis and Baserga, 2001 ) and wild-type 32D cells have been reported to have little PI3-kinase activity, whereas 32D cells expressing exogenous IRS-1 showed increased AKT activation (Valentinis et al., 1999) . We found pAKT slightly elevated in IRS-1-expressing 32D cells and saw a strong increase in pAKT above the levels observed with IRS-1 when co-expressed with wild-type ALK (Figure 5a ). Activation of extracellular-regulated kinase (ERK)1/2 has been shown to be a key event in the entry into the cell cycle and IRS-1 is a mediator not only of the PI3-kinase but also of MAPK signaling cascade (Baserga, 1999 (Baserga, , 2000a Cristofanelli et al., 2000; Valentinis and Baserga, 2001 ). We reported earlier that the activation of ALK by MK can activate MAPK proteins (Stoica et al., 2002) and we compared the Figure 5b shows that in the absence of IL-3 pERK1 is not detected in 32D, 32D/ IRS-1 and 32D/IRS-1/ALKDATP cells, although pERK2 is detected in all cell lines. Activation of pERK2 in the absence of IL-3 has been reported by other groups previously, although the mechanism is unknown (Cristofanelli et al., 2000). Interestingly, elevated pERK1 is observed in 32D/ALK and 32D/IRS-1/ALKDIRS-1 cells, whereas the highest pERK1 levels are detected in 32D/IRS-1/ALK cells. Thus, the pattern of MAPK activation in these cell lines parallels the mitogenic activity observed in the absence of IL-3 (see Figure 2d and e). Also, one could reasonably expect that this MAPK and AKT activation would result in transcriptional activation of downstream pathways involved in mitogenesis and cell survival. This was tested in the next experimental series.
Enhanced NF-kB activation in 32D/IRS-1/ALK cells Transcriptional activation or attenuation is the convergence of intracellular signaling pathways that coordinates cell growth and survival and we next monitored transcriptional activation of pathways that could possibly contribute to the growth phenotype observed. We selected promoter constructs that contain the canonical response elements for AP-1, NF-kB (Karin and Hunter, 1995) , SRE or SRF (Hill et al., 1993; Marais et al., 1993; Price et al., 1995) and drive a luciferase reporter. These promoter/reporters are representative of pathways known to be activated during mitogenesis induced by distinct stimuli and we hypothesized that their differential activation would highlight relevant downstream effectors. 32D parental cells and 32D/IRS-1/ALK cells were transiently transfected with the respective promoter/reporter constructs and firefly luciferase activity was read. A Renilla luciferase reporter plasmid was used as an internal control for transfection efficiency. Quite surprisingly, only the construct containing the NF-kB response element showed a significant and strong induction in 32D/IRS-1/ALK cells (Figure 6a ). Furthermore, only cells containing both ALK and IRS-1 showed this NF-kB activity (Figure 6b not show any induction in any of the cell lines, although a small but inconsistent activation of the AP-1 promoter/reporter was seen with the 32D/IRS-1 ALK cells (Figure 6a ). This lack of AP-1 activity was particularly surprising as control experiments with 32D cells showed that expression of pFC-MEKK, a constitutively active MEKK, induced activation of the AP-1 promoter/ reporter by eightfold (not shown) and AP-1 had been shown by others to be activated by MAPK (Deng and Karin, 1994; Minden et al., 1994) and PI3-kinase (Huang et al., 1996) signaling.
Effect of the knockdown of p65/NF-kB protein in 32D/ IRS-1/ALK cells To investigate the significance of the activation of NFkB described above, we used siRNAs to target the p65 subunit of the NF-kB complex and thus disrupt its functionality. Relative to control siRNA, two different p65 siRNAs depleted the p65 protein ( Figure 7a ) and reduced the proliferation rate of 32D/IRS-1/ALK cells (Figure 7b ). Knock down of p65 did not affect the proliferation of 32D/IRS-1/ALK cells supplemented with IL-3 (data not shown). These data suggest that NF-kB plays a significant role in the growth signaling in 32D/IRS-1/ALK cells and that this is independent of the IL-3 pathway.
Discussion
The results of our present study provide the first documentation that IRS-1 is a rate-limiting factor of proliferation and survival signals provided by the MK/ ALK signaling axis. Although there have been a number of mechanistic studies of ALK signaling, the majority of these reports were performed using ALK fusion or chimeric proteins. Although these studies showed how these ALK fusion proteins can function in physiological and pathological settings, they cannot predict how the full-length ALK protein will function. This is due to a number of significant differences: full-length ALK is a transmembrane receptor tyrosine kinase whereas ALK fusion proteins are usually cytoplasmic proteins with the potential of being translocated into the nucleus. Furthermore, expression of fusion proteins is driven by the 5 0 -fusion gene partner and is usually very high. Finally, domains that promote spontaneous dimerization are part of the NPM-ALK fusion protein and are not present in the full-length ALK. Understanding the mechanisms of the full-length ALK is important because of the growing evidence that full-length ALK expression is frequently expressed in human carcinomas (Lawrence et al., 2000; Powers et al., 2002; Stoica et al., 2002; Li et al., 2004; Osajima-Hakomori et al., 2005) .
We have recently identified ALK as a receptor for PTN and MK (Stoica et al., 2001 . In those reports, we showed that exogenous PTN and MK can stimulate endogenous ALK and result in the activation of IRS-1, SHC and PLC-g proteins in SW13 cells. These findings were recently corroborated by others (Lu et al., 2005) and we discuss the data in support of ALK as a receptor for PTN/MK more extensively in the 'Introduction' section. In the present study, we show that the exogenously transfected ALK in 32D cells is constitutively activated by endogenous ligand, the MK protein (Figures 2-4) and that endogenous MK is required for the activation of mitogenic and survival pathways in these cells. Interestingly, recent studies have revealed that the antiapoptotic activity of MK reduces the sensitivity of cells to cytotoxic drugs used clinically and may thus participate in the development of resistance to chemotherapy (Mirkin et al., 2005) . This type of autocrine stimulation was extensively studied for EGF and IGF-1 receptor-mediated biological functions (Maheshwari et al., 2001; Scharf and Braulke, 2003; Singh and Harris, 2005) and is now also extended to the ALK receptor.
In the present study, we employed two different approaches to investigate the role of IRS-1 protein in ALK signaling. First, we utilized cells that do not express any endogenous ALK or IRS-1 proteins, thereby allowing us to manipulate the system by transfecting them with either ALK or IRS-1 or both. The second approach was to use site-directed mutagenesis to create ALK mutants. One mutant ALK construct was kinase dead (mutated ATP substrate-binding site, ALKDATP), thereby rendering ALK unable to recruit substrates (i.e. IRS-1 and SHC) that required ALK activation. Another mutant construct contained a mutation that would inhibit ALK-IRS-1 interaction (mutated IRS-1 binding site, ALKDIRS-1). With both approaches, we found that IL-3 independence of 32D cell requires the interaction between ALK and IRS-1 proteins. It should be noted that these cells have consistently tested negative for mycoplasma contamination as it has been reported that mycoplasmal infections can induce IL-3 independency in 32D cells (Feng et al., 1999) .
Site-directed mutagenesis studies of NPM-ALK had revealed that PLC-g, but not IRS-1 or SHC, is important for mitogenesis activated by NPM-ALK signaling (Bai et al., 1998) . These data were derived from studies using IL-3-dependent pro-B Ba/F3 cells (Bai et al., 1998) . These results are somewhat different form our findings most likely due to the fact that Ba/F3 cells express at least two IRS proteins, IRS-1 and IRS-2. Studies of IRS-2 have shown that IRS-2 can compensate for IRS-1 when IRS-1 is knocked out. Hence, it is conceivable that a potential IRS-2 binding site on ALK has not been identified and that the binding of IRS-2 can compensate for IRS-1 activity. This scenario is not likely in 32D cells as they do not express any known IRS-1 family member, and the lack of IRS-1 cannot be compensated by another IRS family member. However, it is possible that PLC-g is an additional required substrate for ALK-induced mitogenic signaling in 32D cells. PLC-g proteins are expressed in 32D cells (Heidaran et al., 1993) and we found that the PLC-g binding site on ALK is phosphorylated using a sitespecific antibody (Figures 3a and 4a) .
Activation of growth factor receptors ultimately induces transcription of genes that modulate cell growth and survival. Of the few studies on transcriptional activation using 32D cells, only NF-kB activation has been reported (Reuther et al., 1998; Romano et al., 1999; Zamorano et al., 2001) . As our survey of four different promoter/reporter constructs in 32D and 32D/ IRS-1/ALK cells indicated significant activation only of NF-kB, and PI3-kinase/AKT activation has been shown to induce NF-kB activation (Ozes et al., 1999; Romashkova and Makarov, 1999; Zhou et al., 2000) , we decided to further evaluate NF-kB activity in the different derivative 32D cells. Out of all 32D-transfected cell lines, only 32D/ALK and 32D/IRS/ALK showed any activity, but the most consistent and highest activity was detected in 32D/IRS-1/ALK cells. These results suggest that ALK can drive NF-kB activation, and that activation is increased with the presence of IRS-1. In addition, the lack of activation of AP-1, SRE and SRF promoter/reporter constructs indicates that the ALK/ IRS-1-mediated MAPK and PI3-kinase activity does not cause a global increase of transcription of all mitogenesis-and survival-related pathways Deng and Karin, 1994; Minden et al., 1994; Huang et al., 1996) but instead a relatively selective activation of NF-kB in this cellular context. The significance of this activation is supported by the effect of the knockdown of the p65 subunit of NF-kB, which disrupts the transformed phenotype of the 32D/ IRS-1/ALK cells (Figure 7) . NF-kB is a transcription factor that regulates genes involved in several biological effects such as immune and inflammatory responses, cell proliferation, and cell differentiation and activation of NF-kB in 32D cells has been reported earlier to be involved with antiapoptotic signaling (Reuther et al., 1998; Zamorano et al., 2001; Richmond, 2002) . Recent reports have shown that NFkB plays a role in apoptosis by controlling genes involved in the inhibition of cell death (Wang et al., 1996; Ballinger et al., 1999; Karin and Lin, 2002) . Furthermore, activation of the PI3-kinase/AKT pathway, which contributes to antiapoptotic signaling, can lead to NF-kB activation (Ozes et al., 1999; Romashkova and Makarov, 1999; Zhou et al., 2000) . The principal method of NF-kB activation is through the phosphorylation and degradation of IkB, which liberates NF-kB to translocate into the nucleus. In the nucleus, NF-kB is able to enhance the transcription of a defined set of genes (Richmond, 2002) . However, more recently, different studies have shown an IkB degradationindependent pathway for NF-kB activation. This alternative mechanism of NF-kB involves the phosphorylation of p65 (NF-kB's transactivation subunit) through the PI3kinase/AKT signaling pathway (Ozes et al., 1999; Romashkova and Makarov, 1999; Zhou et al., 2000) . Several studies suggested that it is AKT that directly phosphorylates p65; this suggestion has been the subject to some controversy in the literature and is under intense investigation. It is possible that this alternative mechanism works in 32D/IRS-1/ALK cells. In these cells, IRS-1, PI3-kinase and AKT proteins were all strongly activated. It is conceivable that, in turn, AKT activates NF-kB, which then induces transcription of genes that are involved in survival or mitogenesis.
In conclusion, the present study shows that ALK can transform 32D cells that express IRS-1 owing to MKmediated ALK activation. NF-kB is a major mediator of this signal.
Materials and methods
Construction of expression plasmids and site-directed mutagenesis
The full-length human ALK cDNA was inserted into the pcDNA3.1/Myc-His mammalian expression vector (Invitrogen, Carlsbad, CA, USA). A kinase-dead construct of ALK (ALKDATP) was generated in which the K 1150 residue in the ATP substrate-binding region ( ¼ K 210 in the NPM-ALK fusion protein) was mutated to alanine. An ALK/IRS-1-binding-mutant construct (ALKDIRS-1) was also generated in which the Y 1096 residue in the IRS-1 binding motif NPxY ( ¼ Y 156 in the NPM-ALK fusion protein) was mutated to phenylalanine. Mutant constructs were generated with the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA) with the full-length ALK in pcDNA3.1 as the template. The sense primers were for ALKDATP: CTGCAAGTGGCTGTGGCCACGCTGCCTGAAGTG (GCC replaced AAG in wild-type ALK), for ALKDIRS-1: CCGAC TACAACCCCAACTTCTGCTTTGCTG (T replaced A in wild-type ALK). Mutations were confirmed by sequencing of the mutant expression vectors.
Cell lines, transfections and reporter assays 32D and 32D/IRS-1-transfected cell lines were gifts from Dr L-M Wang (NIH) and were cultured in RPMI 1640 medium with 10% fetal calf serum (FCS) and 5% WEHI-3 cell conditioned media (CM) as a source of IL-3. The COS-7 cells from ATCC were cultured in modified improved minimum essential medium (Gibco, Grand Island, NY, USA) with 10% FCS. 32D cells were electroporated using the BioRad Gene Pulser (Hercules, CA, USA). 7.5 Â 10 6 cells in 300 ml of phosphate-buffered saline (PBS) were mixed with 10 mg of DNA and then pulsed at 280 V and 960 mF. After 24 h, cells were selected with 750 mg/ml of G418. Transient transfections of 32D and COS-7 cells were carried out using FuGENE 6 Transfection Reagent (Roche Applied Science, Indianapolis, IN, USA) following the manufacturer's protocol. Briefly, 7.5 Â 10 4 cells/ml were plated overnight. A 3:2 ratio (FuGENE 6 Reagent: DNA ratio) was used for transfection. The firefly luciferase reporter plasmids (pLuc-MCS, pNF-kB-Luc, pAP-1-Luc, pSRE-Luc and pSRF-Luc) and an expression vector for a constitutively active MAPK, (pFC-MEKK) were from Stratagene (La Jolla, CA, USA). The herpes simplex virus thymidine kinase-driven Renilla luciferase reporter plasmid pRL-TK was used as an internal control for transfection efficiency (Promega, Madison, WI, USA). After 24 h, cells were lysed and the extract was assayed for both firefly and Renilla luciferase activity using the Dual-Luciferase Reporter Assay System (Promega, Madison, WI, USA) following the manufacturer's protocol. Light intensity was measured in a Monolight 2010 luminometer (Analytical Luminescence Laboratory, Sparks, MD, USA).
Antibodies
Antibodies used for IPs were agarose-conjugated a-phosphotyrosine (4G10) (Upstate Biotechnology, Lake Placid, NY, USA) and a-Myc (9E10) (Santa Cruz Biotechnology, Santa Cruz, CA, USA). For immunoblot analysis, rabbit polyclonal antibodies a-ALK, a-phospho-ALK (pY 1604 
IP and immunoblotting
Lysates from serum-starved cells (for 4 h) were prepared in NP-Tris lysis buffer (20 mM Tris-Cl (pH 7.5), 150 mM NaCl, 1% NP-40, 2.5 mM EDTA, 10 mM NaF and 10 mM NaPPi) containing freshly added protease inhibitors (0.3 mM of aprotinin, 4 mM of leupeptin, 0.4 mM Pefabloc SC (Roche Applied Science) and 1 mM pepstatin) and 1 mM Na 3 VO 4 . IPs were performed using 500 mg of lysates with either agarose-conjugated a-Myc or agarose-conjugated a-pY antibody. Proteins were resolved by sodium dodecyl sulfatepolyacrylamide gel electrophoresis on 4-20% Tris-Glycine gels (Invitrogen, Carlsbad, CA, USA) and subsequently immunoblotted with appropriate antibodies.
Knockdown of MK and p65 by siRNA 32D/IRS-1/ALK cells growing in 10% FCS were electroporated with 3 mg of different siRNAs that are targeted to the open reading frames (ORFs) using the Nucleofector (Amaxa Biosystems, Ko¨ln, Germany) according to the manufacturer's protocol (solution R and program T-20 were used). After 5 h, 5 Â 10 4 cells were replated in 10% FCS or 10% FCS and 5% WEHI-3 CM. Forty-eight hours post-electroporation, cells were analysed for proliferation (WST-1 assay; Roche Applied Science, Indianapolis, IN, USA). The control (no-silencing) siRNA was from Qiagnen (Valencia, CA, USA). The sequence of the sense strands of the respective siRNAs is as follows (the nucleotide positions in the ORF is given in parentheses): Cell growth and mitogenesis assay Transfected 32D cells were washed and plated at a density of 5 Â 10 4 cells/ml. Cells were counted using a coulter counter. DNA synthesis in the 32D transfectants was monitored using a colorimetric BrdU incorporation assay (Cell Proliferation ELISA; Roche Applied Science, Indianapolis, IN, USA). For this, 32D cell lines were washed twice with PBS, and plated at a density of 5 Â 10 4 cells/ml. The reading of BrdU incorporation was taken according to the manufacturer's protocol.
Apoptosis assay 32D cells were washed once in PBS, resupended in the appropriate growth media and 3 ml of 10 5 cells/ml were plated in triplicate in six-well plates. After 24 or 48 h, 2 ml of cells from each well were spun down and washed once with cold PBS. Cells were then stained by TACS Annexin V kit (Trevigen, Gaithersburg, MD, USA) following the manufacturer's protocol by flow cytometry within 1 h.
